4//SEC Filing
Metzger Michael A 4
Accession 0000950170-25-039787
CIK 0001395937other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 6:01 AM ET
Size
6.6 KB
Accession
0000950170-25-039787
Insider Transaction Report
Form 4
Metzger Michael A
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Stock options (Right to buy)
2025-03-14+6,074→ 0 totalExercise: $7.20Exp: 2025-06-01→ Common Stock (6,074 underlying) - Exercise/Conversion
Common Stock
2025-03-14$7.20/sh+6,074$43,733→ 306,195 total
Footnotes (1)
- [F1]This option is fully vested.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001507220
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 6:01 AM ET
- Size
- 6.6 KB